Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators. | RSC Med Chem | 2023 | 37731692 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia. | Sci Rep | 2023 | 37730831 | PubTator, text mining | PubMed |
| Significant improvement of systemic lupus erythematosus manifestation in children after autologous dendritic cell transfer: a case report and review of literature. | Ther Adv Vaccines Immunother | 2023 | 37719802 | PubTator, text mining | PubMed |
| IL-21-IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection. | Aging Cell | 2023 | 37712598 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells promote the formation of abdominal aortic aneurysms through the IL-3-ICOSL-ICOS axis. | BBA Adv | 2023 | 37705722 | PubTator, text mining | PubMed |
| Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy. | Exp Mol Med | 2023 | 37696895 | PubTator, text mining | PubMed |
| Double-edged sword: γδ T cells in mucosal homeostasis and disease. | Exp Mol Med | 2023 | 37696894 | PubTator, text mining | PubMed |
| The modulation of pulmonary group 2 innate lymphoid cell function in asthma: from inflammatory mediators to environmental and metabolic factors. | Exp Mol Med | 2023 | 37696890 | PubTator, text mining | PubMed |
| A targeted sequencing extension for transcript genotyping in single-cell transcriptomics. | Life Sci Alliance | 2023 | 37696578 | PubTator, text mining | PubMed |
| Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming. | Cell Mol Life Sci | 2023 | 37688662 | PubTator, text mining | PubMed |
| Development and Validation of the Oxidative Stress Related lncRNAs for Prognosis in Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37686677 | PubTator, text mining | PubMed |
| The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma. | Cancers (Basel) | 2023 | 37686584 | PubTator, text mining | PubMed |
| CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them. | Hemasphere | 2023 | 37674860 | PubTator, text mining | PubMed |
| Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy. | Front Immunol | 2023 | 37671150 | PubTator, text mining | PubMed |
| Chemotherapy tips the scale in favour of cancer-fighting B cells. | Clin Transl Med | 2023 | 37670492 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma. | Front Immunol | 2023 | 37662906 | PubTator, text mining | PubMed |
| Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework. | Eur J Med Res | 2023 | 37649103 | PubTator, text mining | PubMed |
| Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features. | Clin Epigenetics | 2023 | 37644514 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=13